` ALCAR (Carmat SA) vs DAX Index Comparison - Alpha Spread

ALCAR
vs
DAX Index

Over the past 12 months, ALCAR has underperformed DAX Index, delivering a return of -71% compared to the DAX Index's 21% growth.

Stocks Performance
ALCAR vs DAX Index

Loading

Performance Gap
ALCAR vs DAX Index

Loading
ALCAR
DAX Index
Difference

Performance By Year
ALCAR vs DAX Index

Loading
ALCAR
DAX Index
Add Stock

Competitors Performance
Carmat SA vs Peers

DAX Index
ALCAR
ABT
ISRG
BSX
SYK
Add Stock

Carmat SA
Glance View

Market Cap
51.4m EUR
Industry
Health Care

Carmat SA engages in the developing of implantable orthotropic and biocompatible artificial heart. The company is headquartered in Velizy-Villacoublay, Ile-De-France and currently employs 160 full-time employees. The company went IPO on 2010-07-07. The firm is developing an orthotopic and biocompatible artificial heart which works like a natural heart and which is hydraulically activated. The firm formed a network of partnerships with hospitals and various scientific companies, such as The Georges Pompidou European Hospital, The Marie Lannelongue Surgical Center, The Hospital Charles Nicolle of Rouen, Dedienne Sante, PaxiTech, Vignal Artru Industries, French Vessels and Blood Institute, Laboratoire de Recherche Biochirurgicale and others. As of December 31, 2011, a company MATRA DEFENSE held a 30.57% stake in the Company’s shareholdings.

ALCAR Intrinsic Value
3.045 EUR
Undervaluation 71%
Intrinsic Value
Price
Back to Top